{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T19:41:27Z","timestamp":1784835687280,"version":"3.55.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS- 2020-NR051869"],"award-info":[{"award-number":["RS- 2020-NR051869"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.intimp.2025.116023","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T04:12:24Z","timestamp":1766981544000},"page":"116023","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Modulation of airway inflammation by recombinant Der p 38 mutant immunotherapy in a murine model of allergic asthma"],"prefix":"10.1016","volume":"170","author":[{"given":"Min Hwa","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujin","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geunyeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beom Seok","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Sook","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juram","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In Sik","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.intimp.2025.116023_bb0005","first-page":"311","article-title":"Overview of the pharmacogenetics of asthma treatment","volume":"6","author":"Weiss","year":"2006","journal-title":"Pharm. J."},{"issue":"7","key":"10.1016\/j.intimp.2025.116023_bb0010","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/ni.1892","article-title":"The many paths to asthma: phenotype shaped by innate and adaptive immunity","volume":"11","author":"Kim","year":"2010","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2025.116023_bb0015","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1398-9995.2006.01293.x","article-title":"European Community respiratory health survey, geographical variation in the prevalence of positive skin tests to environmental aeroallergens in the European Community respiratory health survey I","volume":"62","author":"Bousquet","year":"2007","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.intimp.2025.116023_bb0020","article-title":"T2-high asthma phenotypes across lifespan","volume":"60","author":"N. Maison, J. Omony, S. Illi, D. Thiele, C. Skevaki, A.M. Dittrich, T. Bahmer, K.F. Rabe, M. Weckmann, C. Happle, B. Schaub, M. Meyer, S. Foth, E. Rietschel, H. Renz, G. Hansen, M.V. Kopp, E. von Mutius, R. Grychtol, A.S. Group, A.S. Group, O. Fuchs, B. Roesler, N. Welchering, N. Kohistani-Greif, J. Kurz, K. Landgraf-Rauf, K. Laubhahn, C. Liebl, M. Ege, A. Hose, E. Zeitlmann, M. Berbig, C. Marzi, C. Schauberger, U. Zissler, C. Schmidt-Weber, I. Ricklefs, G. Diekmann, L. Liboschik, G. Voigt, L. Sultansei, G. Nissen, I.R. Konig, A.M. Kirsten, F. Pedersen, H. Watz, B. Waschki, C. Herzmann, M. Abdo, H. Biller, K.I. Gaede, X. Bovermann, A. Steinmetz, B.L. Husstedt, C. Nitsche, V. Veith, M. Szewczyk, F. Brinkmann, A. Malik, N. Schwerk, C. Dopfer, M. Price, A.C. Jirmo, A. Habener, D.S. DeLuca, S. Gaedcke, B. Liu, M.R. Calveron, S. Weber, T. Schildberg, S. van Koningsbruggen-Rietschel, M. Alcazar","year":"2022","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.intimp.2025.116023_bb0025","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12016-018-8712-1","article-title":"Understanding asthma phenotypes, Endotypes, and mechanisms of disease","volume":"56","author":"Kuruvilla","year":"2019","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2025.116023_bb0030","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.4049\/jimmunol.2001144","article-title":"Der p 38 is a bidirectional regulator of eosinophils and neutrophils in allergy","volume":"207","author":"Hong","year":"2021","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2025.116023_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.646316","article-title":"Pathogenic mechanism of Der p 38 as a novel allergen homologous to RipA and RipB proteins in atopic dermatitis","volume":"12","author":"Jeon","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.116023_bb0040","doi-asserted-by":"crossref","first-page":"206","DOI":"10.15616\/BSL.2023.29.3.206","article-title":"Allergic effects of Der p 38 and Der f 38: a comparison","volume":"29","author":"Lee","year":"2023","journal-title":"Biomed Sci Letters"},{"issue":"1","key":"10.1016\/j.intimp.2025.116023_bb0045","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/all.12890","article-title":"Allergen-specific immunotherapy: is it vaccination against toxins after all?","volume":"72","author":"Bachmann","year":"2017","journal-title":"Allergy"},{"issue":"11","key":"10.1016\/j.intimp.2025.116023_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens10111406","article-title":"Allergen immunotherapy in asthma","volume":"10","author":"Nakagome","year":"2021","journal-title":"Pathogens"},{"issue":"1","key":"10.1016\/j.intimp.2025.116023_bb0055","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jaci.2021.06.012","article-title":"Allergoid-mannan conjugates reprogram monocytes into tolerogenic dendritic cells via epigenetic and metabolic rewiring","volume":"149","author":"Benito-Villalvilla","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2025.116023_bb0060","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3345\/cep.2022.00479","article-title":"New approaches to immunotherapy in house dust mite allergy","volume":"66","author":"Kim","year":"2023","journal-title":"Clin Exp Pediatr"},{"issue":"5","key":"10.1016\/j.intimp.2025.116023_bb0065","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/all.13749","article-title":"EAACI guidelines on allergen immunotherapy: house dust mite-driven allergic asthma","volume":"74","author":"Agache","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.intimp.2025.116023_bb0070","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2147\/JAA.S530738","article-title":"Efficacy and safety of Omalizumab combined with allergen-specific immunotherapy in the treatment of moderate-to-severe allergic asthma: a prospective cohort study in a Chinese population","volume":"18","author":"Liu","year":"2025","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.intimp.2025.116023_bb0075","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1146\/annurev-immunol-030409-101218","article-title":"From allergen genes to allergy vaccines","volume":"28","author":"Valenta","year":"2010","journal-title":"Annu. Rev. Immunol."},{"issue":"7\u20138","key":"10.1016\/j.intimp.2025.116023_bb0080","first-page":"815","article-title":"Genetically engineered and synthetic allergen derivatives: candidates for vaccination against type I allergy","volume":"380","author":"Valenta","year":"1999","journal-title":"Biol. Chem."},{"issue":"11","key":"10.1016\/j.intimp.2025.116023_bb0085","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1096\/fj.01-0016fje","article-title":"Nonanaphylactic synthetic peptides derived from B cell epitopes of the major grass pollen allergen, Phl p 1, for allergy vaccination","volume":"15","author":"Focke","year":"2001","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.intimp.2025.116023_bb0090","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/ACI.0b013e328357ca53","article-title":"Safety of engineered allergen-specific immunotherapy vaccines","volume":"12","author":"Focke-Tejkl","year":"2012","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2025.116023_bb0095","first-page":"857","article-title":"Neuregulin-1 suppresses anti-apoptotic effect of Der p 38 on neutrophils by inhibition of cytokine secretion, molecular and cellular","volume":"19","author":"Hong","year":"2023","journal-title":"Toxicology"},{"key":"10.1016\/j.intimp.2025.116023_bb0100","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.3389\/fimmu.2020.01258","article-title":"S100A8 and S100A9 promote apoptosis of chronic eosinophilic leukemia cells","volume":"11","author":"Lee","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2025.116023_bb0105","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/all.14300","article-title":"Past, present, and future of allergen immunotherapy vaccines","volume":"76","author":"Dorofeeva","year":"2021","journal-title":"Allergy"},{"issue":"7","key":"10.1016\/j.intimp.2025.116023_bb0110","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11882-018-0790-x","article-title":"Next-generation of allergen-specific immunotherapies: molecular approaches","volume":"18","author":"Curin","year":"2018","journal-title":"Curr Allergy Asthma Rep"},{"issue":"Pt A","key":"10.1016\/j.intimp.2025.116023_bb0115","article-title":"Recent advances in improving intranasal allergen-specific immunotherapy; focus on delivery systems and adjuvants","volume":"113","author":"Sadeghi","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"8","key":"10.1016\/j.intimp.2025.116023_bb0120","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1398-9995.2007.01451.x","article-title":"Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study","volume":"62","author":"Jacobsen","year":"2007","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.intimp.2025.116023_bb0125","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nri824","article-title":"The future of antigen-specific immunotherapy of allergy","volume":"2","author":"Valenta","year":"2002","journal-title":"Nat. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2025.116023_bb0130","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1586\/14760584.2015.1050385","article-title":"Current developments for improving efficacy of allergy vaccines","volume":"14","author":"Sandrini","year":"2015","journal-title":"Expert Rev. Vaccines"},{"issue":"5","key":"10.1016\/j.intimp.2025.116023_bb0135","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jaci.2008.09.017","article-title":"Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis","volume":"122","author":"Pauli","year":"2008","journal-title":"J. Allergy Clin. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2025.116023_bb0140","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jaci.2005.06.004","article-title":"Allergen-specific immunotherapy with recombinant grass pollen allergens","volume":"116","author":"Jutel","year":"2005","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2025.116023_bb0145","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/all.14575","article-title":"Personalized medicine for allergy treatment: allergen immunotherapy still a unique and unmatched model","volume":"76","author":"Incorvaia","year":"2021","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.intimp.2025.116023_bb0150","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1038\/s41598-018-21792-1","article-title":"Conformational IgE epitope mapping of Der p 2 and the evaluations of two candidate Hypoallergens for immunotherapy","volume":"8","author":"Reginald","year":"2018","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.intimp.2025.116023_bb0155","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.4049\/jimmunol.1400064","article-title":"Conversion of Der p 23, a new major house dust mite allergen, into a hypoallergenic vaccine","volume":"192","author":"Banerjee","year":"2014","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2025.116023_bb0160","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1111\/j.1365-2222.2008.03042.x","article-title":"Clinical effects of immunotherapy with genetically modified recombinant birch pollen bet v 1 derivatives","volume":"38","author":"Purohit","year":"2008","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.intimp.2025.116023_bb0165","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.molimm.2023.07.004","article-title":"Current practices and future trends in cockroach allergen immunotherapy","volume":"161","author":"Reginald","year":"2023","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.intimp.2025.116023_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.565431","article-title":"Der p 2.1 peptide abrogates house dust mites-induced asthma features in mice and humanized mice by inhibiting DC-mediated T cell polarization","volume":"11","author":"Klein","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.116023_bb0175","doi-asserted-by":"crossref","first-page":"219","DOI":"10.15616\/BSL.2024.30.4.219","article-title":"The inhibitory effect of Duchesnea indica extract on mixed granulocytic asthma due to Der p 38 by inhibiting neutrophil apoptosis","volume":"30","author":"Kim","year":"2024","journal-title":"Biomed Sci Lett"},{"key":"10.1016\/j.intimp.2025.116023_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.599083","article-title":"Toll-like receptor agonists as adjuvants for allergen immunotherapy","volume":"11","author":"Kirtland","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.116023_bb0185","doi-asserted-by":"crossref","first-page":"1421758","DOI":"10.3389\/fimmu.2024.1421758","article-title":"Intranasal administration of a synthetic TLR4 agonist INI-2004 significantly reduces allergy symptoms following therapeutic administration in a murine model of allergic sensitization","volume":"15","author":"Jackson","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.116023_bb0190","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.534501","article-title":"Insights into mucosal innate immune responses in house dust mite-mediated allergic asthma","volume":"11","author":"Abu Khweek","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2025.116023_bb0195","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jaci.2005.03.046","article-title":"Proasthmatic effects and mechanisms of action of the dust mite allergen, Der p 1, in airway smooth muscle","volume":"116","author":"Grunstein","year":"2005","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2025.116023_bb0200","doi-asserted-by":"crossref","unstructured":"M. Focke-Tejkl, M. Weber, K. Niespodziana, A. Neubauer, H. Huber, R. Henning, G. Stegfellner, B. Maderegger, M. Hauer, F. Stolz, V. Niederberger, K. Marth, J. Eckl-Dorna, R. Weiss, J. Thalhamer, K. Blatt, P. Valent, R. Valenta, Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy, J. Allergy Clin. Immunol. 135(5) (2015) 1207\u20137 e1\u201311.","DOI":"10.1016\/j.jaci.2014.09.012"},{"key":"10.1016\/j.intimp.2025.116023_bb0205","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ebiom.2016.08.022","article-title":"Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy","volume":"11","author":"Zieglmayer","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.intimp.2025.116023_bb0210","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.intimp.2018.06.014","article-title":"Phenotype analyses of IL-10-producing Foxp3(\u2212) CD4(+) T cells increased by subcutaneous immunotherapy in allergic airway inflammation","volume":"61","author":"Matsuda","year":"2018","journal-title":"Int. Immunopharmacol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925020120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925020120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T16:59:05Z","timestamp":1771520345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925020120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":42,"alternative-id":["S1567576925020120"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.116023","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulation of airway inflammation by recombinant Der p 38 mutant immunotherapy in a murine model of allergic asthma","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.116023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116023"}}